Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Antisense & Nucleic Acid Drug Development
|
September 13, 2000
Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells
S Cogoi, C Suraci, E Del Terra, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 19, 2007
Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function
D Pitocco, E DiStasio, A Crinò, et al.
Diabetes Research and Clinical Practice
|
February 17, 2005
Contraception in diabetic women: an Italian study
A Napoli, A Colatrella, R Botta, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 1, 2006
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes
A Picardi, N Visalli, A Lauria, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
October 5, 2005
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus
A Crinó, R Schiaffini, P Ciampalini, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 17, 2006
The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)
D Pitocco, A Crinò, E Di Stasio, et al.
European Journal of Endocrinology
|
May 11, 2004
A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX)
A Crinò, R Schiaffini, S Manfrini, et al.
Diabetologia
|
September 16, 2000
No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group
P Pozzilli, D Pitocco, N Visalli, et al.
Diabetes/Metabolism Research and Reviews
|
August 10, 1999
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI)
N Visalli, M G Cavallo, A Signore, et al.
European Journal of Endocrinology
|
October 23, 1997
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)
P Pozzilli, N Visalli, M G Cavallo, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Antisense & Nucleic Acid Drug Development
|
September 13, 2000
Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells
S Cogoi, C Suraci, E Del Terra, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 19, 2007
Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function
D Pitocco, E DiStasio, A Crinò, et al.
Diabetes Research and Clinical Practice
|
February 17, 2005
Contraception in diabetic women: an Italian study
A Napoli, A Colatrella, R Botta, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 1, 2006
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes
A Picardi, N Visalli, A Lauria, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
October 5, 2005
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus
A Crinó, R Schiaffini, P Ciampalini, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 17, 2006
The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI)
D Pitocco, A Crinò, E Di Stasio, et al.
European Journal of Endocrinology
|
May 11, 2004
A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX)
A Crinò, R Schiaffini, S Manfrini, et al.
Diabetologia
|
September 16, 2000
No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group
P Pozzilli, D Pitocco, N Visalli, et al.
Diabetes/Metabolism Research and Reviews
|
August 10, 1999
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI)
N Visalli, M G Cavallo, A Signore, et al.
European Journal of Endocrinology
|
October 23, 1997
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)
P Pozzilli, N Visalli, M G Cavallo, et al.
Page
of 4